Psychedelic therapy can benefit individuals with PTSD, but can it also help couples better deal with this condition? Randy Lail enters MDMA-assisted psychotherapy treatment with his partner and participates in an MDMA study focused on couples. “After the division, the two parts of man, each desiring his other half, came together, and throwing their arms
The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) communicated publicly about psychedelic drug development and current thinking around safety, therapeutic use, and research. The FDA Division of Psychiatry Products provided information in a workshop about how to design and efficiently study psychedelics for potential medical use.
Six phase 2 trials investigated MDMA-assisted psychotherapy for treatment of PTSD. Results that led to Breakthrough Therapy designation are now published.
Here, take these pills. It will make you better. Likely you’ve heard these phrases before if you’re living in a medicalized society. For whatever ails you, there is a pill or an entire arsenal of medications that your doctor may prescribe. Some of these drugs are life-saving remedies with biological targets that interrupt disease progression
Patchwork Art from MAPS Therapist Training Program 2017Photo Credit: Alyssa Gursky Findings from the last study in a series of six Phase 2 trials of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder (PTSD) was published today in the Journal of Psychopharmacology . The clinical trial in Boulder, Colorado (MP-12) enrolled 28 participants suffering from
The first clinical trial in adults on the autism spectrum investigating MDMA, or any psychedelic substance for that matter, was published in Psychopharmacology this week . This groundbreaking research looked at whether MDMA combined with psychotherapy could help with the severe social anxiety that autistic adults commonly experience. The drug-therapy combo wasn’t intended to be
Originally published on Chacruna.net by Dr. Alli Feduccia Clinical trials of MDMA, psilocybin, ketamine, and ayahuasca are offering a glimpse that the future may hold psychiatric treatments far different from daily drug prescriptions currently used for anxiety and addictive disorders. Research is only beginning to unravel how these experiences in altered states of consciousness produce large shifts
You could be eligible to participate in a psychedelic research trial. Studies of psychedelics are at various stages, enrolling both healthy volunteers and individuals with specific mental health conditions. We’ve compiled a list here of all the current or planned clinical trials on MDMA, psilocybin, LSD, Cannabis, and more. Regulatory approvals over the last few
A common question about the recent wave of psychedelic research is, “how do these mind-altering substances work in the brain to produce a rapid reduction of symptoms and long-lasting improvements for a variety of mental health disorders?” Beyond some scientifically well-founded hypotheses and pure speculation, we haven’t had enough experimental evidence on psychedelics to draw